Literature DB >> 14981786

Expression of aromatase mRNA and effects of aromatase inhibitor during ovarian development in the medaka, Oryzias latipes.

Aya Suzuki1, Minoru Tanaka, Naoki Shibata, Yoshitaka Nagahama.   

Abstract

In teleost fish, several studies have implicated estrogens in the process of ovarian development, but the exact role of endogenous estrogen is still unclear. We examined the expression of aromatase mRNA with in situ hybridization, and the effects of Fadrozole, a nonsteroidal aromatase inhibitor (AI), during ovarian development in medaka Oryzias latipes. Medaka aromatase was first detected on the ventral side of ovaries from four to 10 days after hatching (dah), after occurrence of oogenesis. AI treatment after hatching suppressed the ovarian cavity formation from 30 dah but did not affect early oogenesis and folliculogenesis during ovarian development. These results suggest that endogenous estrogen is specifically required for formation of the ovarian cavity, but is not essential for early oogenesis and folliculogenesis in medaka. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981786     DOI: 10.1002/jez.a.20027

Source DB:  PubMed          Journal:  J Exp Zool A Comp Exp Biol        ISSN: 1548-8969


  13 in total

1.  Germ cells are essential for sexual dimorphism in the medaka gonad.

Authors:  Hiromi Kurokawa; Daisuke Saito; Shuhei Nakamura; Yuko Katoh-Fukui; Kohei Ohta; Takashi Baba; Ken-ichiro Morohashi; Minoru Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-16       Impact factor: 11.205

2.  Identification of genes involved in gonadal sex differentiation and the dimorphic expression pattern in Takifugu rubripes gonad at the early stage of sex differentiation.

Authors:  Hongwei Yan; Xufang Shen; Xin Cui; Yumeng Wu; Lianshun Wang; Lei Zhang; Qi Liu; Yusheng Jiang
Journal:  Fish Physiol Biochem       Date:  2018-05-18       Impact factor: 2.794

Review 3.  Genetics of sexual development: an evolutionary playground for fish.

Authors:  Corina Heule; Walter Salzburger; Astrid Böhne
Journal:  Genetics       Date:  2014-03       Impact factor: 4.562

4.  Aromatase distribution and regulation in fish.

Authors:  Francesc Piferrer; Mercedes Blázquez
Journal:  Fish Physiol Biochem       Date:  2005-04       Impact factor: 3.014

5.  Rspo1-activated signalling molecules are sufficient to induce ovarian differentiation in XY medaka (Oryzias latipes).

Authors:  Linyan Zhou; Tapas Charkraborty; Qian Zhou; Sipra Mohapatra; Yoshitaka Nagahama; Yueguang Zhang
Journal:  Sci Rep       Date:  2016-01-19       Impact factor: 4.379

6.  R-spondins are involved in the ovarian differentiation in a teleost, medaka (Oryzias latipes).

Authors:  Linyan Zhou; Tapas Charkraborty; Xiangguo Yu; Limin Wu; Gang Liu; Sipra Mohapatra; Deshou Wang; Yoshitaka Nagahama
Journal:  BMC Dev Biol       Date:  2012-12-07       Impact factor: 1.978

7.  Estrogen oversees the maintenance of the female genetic program in terminally differentiated gonochorists.

Authors:  B Paul-Prasanth; R K Bhandari; T Kobayashi; R Horiguchi; Y Kobayashi; M Nakamoto; Y Shibata; F Sakai; M Nakamura; Y Nagahama
Journal:  Sci Rep       Date:  2013-10-07       Impact factor: 4.379

8.  Sex-reversal and Histopathological Assessment of Potential Endocrine-Disrupting Effects of Graphene Oxide on Japanese medaka (Oryzias latipes) Larvae.

Authors:  Anitha Myla; Asok K Dasmahapatra; Paul B Tchounwou
Journal:  Chemosphere       Date:  2021-05-17       Impact factor: 8.943

9.  Antiestrogens inhibit xenoestrogen-induced brain aromatase activity but do not prevent xenoestrogen-induced feminization in Japanese medaka (Oryzias latipes).

Authors:  Adam J Kuhl; Marius Brouwer
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

10.  Autosomal gsdf acts as a male sex initiator in the fish medaka.

Authors:  Xi Zhang; Guijun Guan; Mingyou Li; Feng Zhu; Qizhi Liu; Kiyoshi Naruse; Amaury Herpin; Yoshitaka Nagahama; Jiale Li; Yunhan Hong
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.